SIM
KZR

Spark Investment Management’s Kezar Life Sciences KZR Stock Holding History

Spark Investment Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,570
Closed -$81K – 70
2020
Q2 		$81K Sell
1,570
-20
-1% -$1.01K 0.3% 53
2020
Q1 		$69K Buy
+1,590
New +$64.7K 0.04% 307
2019
Q2 		– Sell
-2,120
Closed -$376K – 644
2019
Q1 		$376K Buy
2,120
+1,179
+125% +$232K 0.02% 429
2018
Q4 		$222K Buy
+941
New +$230K 0.02% 489

Other funds holding KZR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Spark Investment Management's KZR Position: Q3 2020 in Review

Spark Investment Management sold out of Kezar Life Sciences (KZR) in Q3 2020, closing a stake of 1,570 shares — an estimated $81K sold.

Spark Investment Management first reported a position in KZR in Q4 2018 and held it in 4 quarters. The position peaked at $376K in Q1 2019. 78 funds tracked by Wall St. Rank hold KZR as of Q3 2020.

  • Spark Investment Management reported no remaining Kezar Life Sciences position as of Q3 2020 after selling out during the quarter.
  • Spark Investment Management sold 1,570 Kezar Life Sciences shares in Q3 2020, an estimated $81K.
  • Spark Investment Management first reported a position in Kezar Life Sciences in Q4 2018 and held it in 4 quarters.
  • Spark Investment Management's Kezar Life Sciences position peaked at $376K in Q1 2019.
  • 78 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2020.

Based on Spark Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.